Phase III Vivacity-MG3 trial shows that nipocalimab, an investigational FcRn blocker, significantly the improves symptoms of generalized myasthenia gravis with a manageable safety profile.

"I can walk out that door and know I am not going to fall," Starkweather said after receiving much needed home renovations.

What the Report Says About Harassment in Online Gaming. The newly released ADL report, "Playing with Hate: How People with ...

Trump revokes US sanctions as 12 hurt in West Bank attacks by Israeli settlers - Gaza receives 915 trucks carrying aid and ...

"Medical Journeys" chart a path each step of ... mild functional impairment on instrumental activities of daily living (ADL) but independence in basic ADL. Stage 5 adds moderate functional ...

Anavex Life Sciences' Blarcamesine trial raises concerns over approval. Learn why AVXL stock is undervalued, reflecting the ...

Waterlily is a platform that uses artificial intelligence to predict a client's need for long-term care and helps them plan to pay for it ...

It's important to understand who may qualify for long-term care insurance coverage if you're planning to buy a policy this ...

Elon Musk, a figure who thrives in the eye of the storm, has once again found himself embroiled in controversy—this time over a gesture some claim resembles a Nazi salute. During a speech at Donald ...

A visit to AmericaFest with the Harvard-educated, show tunes-loving Orthodox Jew from deep blue L.A. who harnessed anti-woke ...